2025 Gold Copd Guidelines. Dupilumab, ensifentrine added to 2025 gold guidelines for copd: Shifts in thinking about copd.

The 2025 gold copd report includes a new emphasis on cv disease and ph in copd and major updates on spirometry, new copd drugs, climate change, and more. A diagnosis of copd should be considered in any patient who has dyspnea, chronic cough or sputum production, a history of recurrent lower respiratory tract infections.